34 results
PX14A6G
MKT Capital Ltd.
6 Jul 23
Letter to shareholders
8:33am
-designated directors in the boardroom to help oversee a credible, comprehensive strategic review to maximize shareholder value.
After seeing
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
2 May 23
Additional proxy soliciting materials
4:39pm
for shareholders. Each member of the Board has played an integral role in our progress to date. Our directors have the expertise needed to oversee and guide
S-3ASR
EX-1.2
wyae2my
19 Nov 21
Automatic shelf registration
5:04pm
DEF 14A
r52jl5jv9azq
10 May 21
Definitive proxy
4:06pm
PRE 14A
6lyk8t7s7jd8y5u1
27 Apr 21
Preliminary proxy
4:32pm
6-K
EX-99.2
hsbmam7kodiwk5l
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.3
0pofx1uvhljtsko6
23 Jul 20
Material Change Report
5:05pm
6-K
EX-99.3
dsnnm
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
40-F
EX-99.1
2lejig5v 762
5 Mar 20
Annual report (Canada)
4:06pm
6-K
EX-99.2
a43omxr 28wg
10 Dec 19
Aurinia Prices US$166.7 Million Public Offering of Common Shares
6:11am
6-K
EX-99.1
xnqbszd
7 Jun 19
Aurinia Issues Letter to Shareholders
8:00am
6-K
EX-99.2
drqydcimkwhdxd6ge
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.1
6cuirq1mmq
19 Mar 19
Annual report (Canada)
4:16pm
6-K/A
EX-99.3
m0gytmdr rtd
17 May 18
Current report (foreign) (amended)
12:00am
40FR12B/A
EX-99.22
6u28oykz0
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.21
tk6o5m
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am